Skip to main content
Log in

Tumeur myofibroblastique inflammatoire gastrique: une localisation inhabituelle, à propos d’un cas

Inflammatory myofibroblastic tumor of the stomach: uncommon site, about one case

  • Cas Clinique / Case Report
  • Published:
Journal Africain d'Hépato-Gastroentérologie

Résumé

Les tumeurs myofibroblastiques inflammatoires (TMI) sont des tumeurs de classe intermédiaire. Elles sont rares et d’étiologie inconnue. Décrites initialement au niveau des poumons, elles ont été observées dans plusieurs autres localisations, essentiellement abdominales et pelviennes. Sa localisation au niveau de l’estomac est extrêmement rare. Nous rapportons l’observation d’une patiente âgée de 52 ans, qui présentait une tumeur gastrique de localisation extraluminale associée à une sensibilité épigastrique sans masse palpable. L’échographie et le scanner abdominal ont mis en évidence une masse de 7 cm siégeant entre le foie et l’estomac. Après l’exérèse chirurgicale de cette masse, l’examen histologique et immunohistochimique était en faveur d’une TMI gastrique. Les caractéristiques cliniques et histologiques de cette entité anatomoclinique seront discutées à la lumière des données de la littérature.

Abstract

Inflammatory myofibroblastic tumor (IMT) is a clinical and pathological disease entity, which is an inflammatory lesion with unknown etiology and is classified as intermediate neoplasm in theWorld Health Organization histological typing. It usually originates from the lung, but can also arise in any sites in the body. IMT of the stomach in adults is extremely rare, with unpredictable prognosis. We present a 52-year-old woman with exophytic tumor of the stomach. Physical examination showed mild abdominal tenderness in the hypogastrium, but no palpable abdominal mass. Abdominal CT scan showed a mass of approximately 7 cm, between stomach and liver. The final diagnosis was consistent with the IMT that originated from the gastric wall. The clinical and histopathological features of this rare lesion are described with a review of the previously reported cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Tanaka A, Hirabayashi K, Sadahiro S, et al (2010) Inflammatory myofibroblastic tumor of the ascending colon in adults manifested by positive fecal occult blood test. Gastrointest Endosc 71(1):214–6

    Article  PubMed  Google Scholar 

  2. Coffin CM, Hornick JL, Fletcher CD (2007) Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 31:509–20

    Article  PubMed  Google Scholar 

  3. Pratap A, Tiwari A, Agarwal B, et al (2007) Inflammatory myofibroblastic tumor of the abdominal wall simulating rhabdomyosarcoma: report of a case. Surg Today 37:352–5

    Article  PubMed  Google Scholar 

  4. Leon CJ, Castillo J, Mebold J, et al (2006) Inflamatory myofibroblastic tumor of the stomach: an unusual complication after gastrectomy. Gastrointest Endosc 63:347–9

    Article  PubMed  Google Scholar 

  5. Coffin CM, Fletcher JA (2002) Inflammatory myofibroblastic tumor. In: Fletcher CDM, Unni KK, Mertens F (eds) Pathology and genetics of tumors of soft tissue and bone. World Health Organization Classification of Tumors. IARC Press, Lyon, pp 91–3

    Google Scholar 

  6. Chan JKC (1995) Inflammatory pseudotumor: a family of lesions of diverse nature and etiologies. Adv Anat Pathol 3:156–71

    Article  Google Scholar 

  7. Coffin CM, Dehner LP, Meis-Kindblom JM (1998) Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. Semin Diagn Pathol 15:102–10

    CAS  PubMed  Google Scholar 

  8. Souid AK, Ziemba MC, Dubansky AS, et al (1993) Inflammatory myofibroblastic tumor in children. Cancer 72:2042–8

    Article  CAS  PubMed  Google Scholar 

  9. Coffin CM, Humphrey PA, Dehner LP (1998) Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol 15:85–101

    CAS  PubMed  Google Scholar 

  10. Coffin CM, Patel A, Perkins S, et al (2001) ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol 14:569–76

    Article  CAS  PubMed  Google Scholar 

  11. Yousem SA, Shaw H, Cieply K (2001) Involvement of 2p23 in pulmonary inflammatory pseudotumors. Hum Pathol 32:428–33

    Article  CAS  PubMed  Google Scholar 

  12. Lewis JT, Gaffney RL, Casey MB, et al (2003) Inflammatory pseudotumor of the spleen associated with a clonal Epstein-Barr virus genome. Case report and review of the literature. Am J Clin Pathol 120:56–61

    Article  PubMed  Google Scholar 

  13. Gomez-Roman JJ, Sanchez-Velasco P, Ocejo-Vinyals G, et al (2001) Human herpesvirus-8 genes are expressed in pulmonary inflammatory myofibroblastic tumor (inflam matory pseudotumor). Am J Surg Pathol 25:624–9

    Article  CAS  PubMed  Google Scholar 

  14. Coffin CM, Patel A, Perkins S, et al (2001) ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol 14: 569–76

    Article  CAS  PubMed  Google Scholar 

  15. Cook JR, Dehner LP, Collins MH, et al (2001) Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 25:1364–71

    Article  CAS  PubMed  Google Scholar 

  16. Griffin CA, Hawkins AL, Dvorak C, et al (1999) Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res 59:2776–80

    CAS  PubMed  Google Scholar 

  17. Yousem SA, Shaw H, Cieply K (2001) Involvement of 2p23 in pulmonary inflammatory pseudotumors. Hum Pathol 32:428–33

    Article  CAS  PubMed  Google Scholar 

  18. Biselli R, Ferlini C, Fattorossi A, et al (1996) Inflammatory myofibroblastic tumor (inflammatory pseudotumor): DNA flow cytometric analysis of nine pediatric cases. Cancer 77:778–84

    Article  CAS  PubMed  Google Scholar 

  19. Hussong JW, Brown M, Perkins SL, et al (1999) Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors. Mod Pathol 12:279–86

    CAS  PubMed  Google Scholar 

  20. Yamamoto H, Oda Y, Saito T, et al (2003) P53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumors. Histopathology 42:431–9

    Article  CAS  PubMed  Google Scholar 

  21. Dishop MK, Warner BW, Dehner LP, et al (2003) Successful treatment of inflammatory myofibroblastic tumor with malignant transformation by surgical resection and chemotherapy. J Pediatr Hematol Oncol 25:153–8

    Article  PubMed  Google Scholar 

  22. Su W, Ko A, O’Connell T, Applebaum H (2000) Treatment of pseudotumors with nonsteroidal anti-inflammatory drugs. J Pediatr Surg 35:1635–7

    Article  CAS  PubMed  Google Scholar 

  23. Williams ME, Longmaid HE, Trey G, et al (1998) Renal failure resulting from infiltration by inflammatory myofibroblastic tumor responsive to corticosteroid therapy. Am J Kidney Dis 31(6):E5

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Zouaidia.

About this article

Cite this article

Zouaidia, F., Jahid, A., El ouazzani, H. et al. Tumeur myofibroblastique inflammatoire gastrique: une localisation inhabituelle, à propos d’un cas. J Afr Hepato Gastroenterol 4, 241–245 (2010). https://doi.org/10.1007/s12157-010-0202-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12157-010-0202-x

Mots clés

Keywords

Navigation